Cedars-Sinai · 3 weeks ago
Clinical Program Manager for Quality (BMT/CAR T) - Hybrid
8700 Beverly Blvd, Los Angeles, CA, 90048, US
Full-time
Hybrid
Senior Level
$131K/yr - $210K/yrCedars-Sinai is a leading medical center recognized for its excellence in patient care and innovative treatments. The Clinical Program Manager for Quality in the Hematology and Cellular Therapy Division is responsible for driving operational efficiency and clinical excellence while overseeing multidisciplinary teams and ensuring compliance with accreditation standards. This role blends advanced clinical expertise with strategic leadership to enhance patient outcomes and support departmental goals.
CommunitiesHealth CareMedicalNon Profit
Responsibilities
Develops, implements, maintains and improves as necessary a Quality program(s) for the care of Hematology and Cellular Therapy patients, as appropriate for the role during pre-transplant/pre-cellular therapy work up, treatment, and post-transplant/cellular therapies, ensuring compliance with Foundation for the Accreditation of Cellular Therapy (FACT), Hematopoietic progenitor Cell, Immune Effector Cell, and adherence to SOPs and CSMC Administrative Policies
Performs surveillance audits, analyzes data, writes reports in accordance with FACT accreditation standards. Maintains a log with information related to events that are considered a deviation from standards of care, or policy. This includes patient information, deviation, remedy and implementation of changes to prevent recurrence. This log must be available to present and speak to with accrediting bodies
Prepares, schedules, organizes, and leads all QA meetings, Morbidity & Mortality and AE reviews, SOP meetings, and other ad hoc QA related meetings. Responsible for post-meeting duties involving minutes, reports, event forms, filing, etc
Acts as point of contact and lead onsite liaison for FACT accreditation agency. Responsible for FACT applications completions and program readiness for accreditation inspections
Owns TCT program SOPs with duties that include oversight in the Policy and Procedure Management (PPM) system in accordance with the practice requirements of the OLAR/PPM dept. Ensures that SOPs are reviewed no less than every 2 years as well as manage SOP that require edits due to practice changes. Is point of contact and oversight for OLAR/PPM dept
Qualification
Required
Strong foundation in clinical practice, leadership, and education to design and implement effective care models
Experience in developing, implementing, maintaining and improving Quality program(s) for the care of Hematology and Cellular Therapy patients
Knowledge of compliance with Foundation for the Accreditation of Cellular Therapy (FACT), Hematopoietic progenitor Cell, Immune Effector Cell, and adherence to SOPs and CSMC Administrative Policies
Ability to perform surveillance audits, analyze data, and write reports in accordance with FACT accreditation standards
Experience in maintaining logs with information related to events that are considered a deviation from standards of care or policy
Ability to prepare, schedule, organize, and lead QA meetings, Morbidity & Mortality and AE reviews, SOP meetings, and other ad hoc QA related meetings
Experience acting as point of contact and lead onsite liaison for FACT accreditation agency
Ability to own TCT program SOPs with duties that include oversight in the Policy and Procedure Management (PPM) system
Benefits
Outstanding benefit package
Competitive salaries
Learning programs
Tuition reimbursement
Performance-improvement projects
Company
Cedars-Sinai
Since its beginning in 1902, Cedars-Sinai has evolved to meet the healthcare needs of one of the most diverse regions in the nation, continually setting new standards for quality and innovation in patient care, research, teaching and community service.
Founded in 1902
10001+ employees
H1B Sponsorship
Cedars-Sinai has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (105)
2024 (91)
2023 (81)
2022 (92)
2021 (92)
2020 (65)
Funding
Current Stage
Late StageTotal Funding
$63.31MKey Investors
American Academy of Orthopaedic SurgeonsCalifornia HealthCare FoundationNational Heart, Lung and Blood Institute
2023-12-01Grant· $0.01M
2023-05-25Grant· $28M
2022-06-16Grant· $7M
Leadership Team
Thomas Priselac
President/CEO
David Wrigley
Executive Vice President Finance, CFO and Treasurer
Recent News
Medical Xpress - latest medical and health news stories
2025-12-17
Medical Xpress - latest medical and health news stories
2025-12-17
Company data provided by crunchbase